2023 Team Kopacz funding priorities:
The first $25,000 will go to the U of MN SPARX3 clinical trial to fund the study coordinator to accelerate enrollment. Our funding over the previous 3 years has been vital to the success of this important research. Any additional funds raised will go to The Michael J Fox Foundation for Parkinson's Research.
The first $25,000 will go to the U of MN SPARX3 clinical trial to fund the study coordinator to accelerate enrollment. Our funding over the previous 3 years has been vital to the success of this important research. Any additional funds raised will go to The Michael J Fox Foundation for Parkinson's Research.
